(FSMD) Fidelity Small-Mid Factor - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3160925273 • Small Blend

FSMD: Stocks, Small-Cap, Mid-Cap, U.S. Companies

The Fidelity Small-Mid Factor ETF (FSMD) is designed to capture the performance of small- and mid-capitalization U.S. companies that exhibit attractive valuations, strong financial quality, positive momentum, and lower volatility compared to the broader market. The fund typically allocates at least 80% of its assets to securities included in the Fidelity Small-Mid Multifactor Index. This index is constructed to reflect the performance of companies with appealing valuation metrics, such as low price-to-earnings and price-to-book ratios, while also incorporating measures of profitability and financial health. Additionally, the index considers momentum factors, such as recent price performance, and volatility metrics to identify more stable investments within the small- and mid-cap universe.

As of the latest data, the fund has approximately $913.95M in assets under management, making it a sizable player in the small-mid cap ETF space. The ETF is listed on the NYSE Arca exchange under the ticker symbol FSMD and falls under the Small Blend category. By focusing on a combination of value, quality, and momentum, FSMD aims to provide investors with exposure to smaller companies that may offer growth potential while maintaining a more stable portfolio compared to broader small- and mid-cap indices.

Looking ahead, the future outlook for FSMD, as one might analyze it through the lens of valuation and market fundamentals, could be influenced by several key factors. Small- and mid-cap companies, which FSMD targets, are often more sensitive to economic cycles and interest rate changes. If interest rates remain low or stable, these companies could benefit from easier access to capital and higher valuations. Additionally, the funds focus on lower volatility could make it more resilient during periods of market uncertainty. However, the performance of FSMD will also depend on the ability of its underlying companies to maintain their financial health and growth trajectories. As with any factor-based investment strategy, the interplay between value, quality, and momentum will be critical in determining the funds long-term success.

Additional Sources for FSMD ETF

FSMD ETF Overview

Market Cap in USD 1,240m
Category Small Blend
TER 0.15%
IPO / Inception 2019-02-26

FSMD ETF Ratings

Growth Rating 68.6
Fundamental -
Dividend Rating 54.2
Rel. Strength -4.92
Analysts -
Fair Price Momentum 35.45 USD
Fair Price DCF -

FSMD Dividends

Dividend Yield 12m 1.41%
Yield on Cost 5y 2.85%
Annual Growth 5y 7.03%
Payout Consistency 100.0%

FSMD Growth Ratios

Growth Correlation 3m -91.6%
Growth Correlation 12m 42.3%
Growth Correlation 5y 79.8%
CAGR 5y 14.44%
CAGR/Max DD 5y 0.65
Sharpe Ratio 12m -0.64
Alpha -4.98
Beta 0.924
Volatility 33.26%
Current Volume 798.7k
Average Volume 20d 808.1k
What is the price of FSMD stocks?
As of April 25, 2025, the stock is trading at USD 38.15 with a total of 798,737 shares traded.
Over the past week, the price has changed by +3.08%, over one month by -4.39%, over three months by -10.86% and over the past year by +4.16%.
Is Fidelity Small-Mid Factor a good stock to buy?
Yes. Based on ValueRay Analyses, Fidelity Small-Mid Factor (NYSE ARCA:FSMD) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.61 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FSMD as of April 2025 is 35.45. This means that FSMD is currently overvalued and has a potential downside of -7.08%.
Is FSMD a buy, sell or hold?
Fidelity Small-Mid Factor has no consensus analysts rating.
What are the forecast for FSMD stock price target?
According to ValueRays Forecast Model, FSMD Fidelity Small-Mid Factor will be worth about 39.8 in April 2026. The stock is currently trading at 38.15. This means that the stock has a potential upside of +4.22%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 39.8 4.2%